Extracellular Vesicles in Gut‐Bone Axis: Novel Insights and Therapeutic Opportunities for Osteoporosis DOI Creative Commons
Han Liu, Ruiyang Li, Huijian Yang

et al.

Small Science, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 23, 2024

Osteoporosis (OP) is a systemic and retrogressive disease characterized by decreased bone density fragile microstructure. Extracellular vesicles (EVs), cell‐free system with phospholipid bilayer released cells that cannot be replicated, have unique nanostructure, stable drug‐loading capacity, good biocompatibility, playing an important role in regulating the gut‐skeletal axis. A growing body of research demonstrates gut microbiota (GM) influence development OS, while bacteria‐derived EVs (BEVs) become new dialogue medium between bone. Additionally, organoids are 3D cell clusters vitro highly simulate structure function corresponding organs. Intestinal organoids‐derived (IOEVs) serve as another promising communication due to their significant physiological effects. Herein, three types gut‐bone axes, including traditional, BEVs‐based, IOEVs‐based axes innovatively proposed. The impact BEVs‐based on OP focused. comprehensive summary will reveal relationship intestinal provide solution therapy.

Language: Английский

Bone aging and extracellular vesicles DOI
Jian Wang, Yuanwei Zhang, Sicheng Wang

et al.

Science Bulletin, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

Citations

3

Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases DOI Creative Commons

Shanshan Nie,

Shan Zhang, Ruipeng Wu

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: Nov. 7, 2024

Scutellarin (SCU), a flavonoid glucuronide derived from Scutellaria barbata and Erigeron breviscapus , exhibits broad pharmacological effects with promising therapeutic potential in treating various chronic diseases. It has demonstrated efficacy modulating multiple biological pathways, including antioxidant, anti-inflammatory, anti-apoptotic, vasodilatory mechanisms. These protective roles make SCU valuable compound diseases such as cerebrovascular diseases, cardiovascular neurodegenerative disorders, metabolic Despite its multi-targeted effects, faces challenges low bioavailability limited clinical data, which hinder widespread application. Current research supports to prevent oxidative stress, reduce inflammatory responses, enhance cell survival cells rats. However, more comprehensive studies are required clarify molecular mechanisms develop strategies that for use. could emerge potent agent the treatment of complex pathophysiological This review examines current literature on provide understanding activity, action,

Language: Английский

Citations

3

Lactobacillus rhamnosus GG-derived extracellular vesicles promote wound healing via miR-21-5p-mediated re-epithelization and angiogenesis DOI Creative Commons
Juan Wang,

Xiaojie Li,

Xinyue Zhao

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Oct. 19, 2024

Extracellular vesicles (EVs), especially those derived from stem cells, have emerged as a novel treatment for promoting wound healing in regenerative medicine. However, the clinical application of mammalian cells-derived EVs is hindered by their high cost and low yields. Inspired ability to mediate interkingdom communication, we explored therapeutic potential released probiotic strain Lactobacillus rhamnosus GG (LGG) skin elucidated underlying mechanism involved. Using full-thickness wound-healing mouse models, found that LGG-EVs accelerated procedures, including increased re-epithelialization promoted angiogenesis. vitro experiments, further demonstrated boosted proliferation migration capacities both epithelial endothelial well tube formation. miRNA profiling analysis revealed miR-21-5p was highly enriched LGG-EV significantly level recipient cells. Mechanically, induced regulatory effects via mediated metabolic signaling rewiring. Our results suggest LGG could serve promising candidate accelerating possibly treating chronic impaired conditions.

Language: Английский

Citations

1

Gut microbiome and bone health: update on mechanisms, clinical correlations, and possible treatment strategies DOI
Andrea Ticinesi, Carmine Siniscalchi, Tiziana Meschi

et al.

Osteoporosis International, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 7, 2024

Language: Английский

Citations

1

Extracellular Vesicles in Gut‐Bone Axis: Novel Insights and Therapeutic Opportunities for Osteoporosis DOI Creative Commons
Han Liu, Ruiyang Li, Huijian Yang

et al.

Small Science, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 23, 2024

Osteoporosis (OP) is a systemic and retrogressive disease characterized by decreased bone density fragile microstructure. Extracellular vesicles (EVs), cell‐free system with phospholipid bilayer released cells that cannot be replicated, have unique nanostructure, stable drug‐loading capacity, good biocompatibility, playing an important role in regulating the gut‐skeletal axis. A growing body of research demonstrates gut microbiota (GM) influence development OS, while bacteria‐derived EVs (BEVs) become new dialogue medium between bone. Additionally, organoids are 3D cell clusters vitro highly simulate structure function corresponding organs. Intestinal organoids‐derived (IOEVs) serve as another promising communication due to their significant physiological effects. Herein, three types gut‐bone axes, including traditional, BEVs‐based, IOEVs‐based axes innovatively proposed. The impact BEVs‐based on OP focused. comprehensive summary will reveal relationship intestinal provide solution therapy.

Language: Английский

Citations

1